NUCLEUS
"NUCLEUS" is a word mark owned by Simulations Plus, Inc., filed at the USPTO on October 21, 2022. It is under examination and covers classes 9, 35, 36, 38, 41 and 42.
- Status
- Under examination
- Since May 23, 2026
- Filed
- October 21, 2022
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 97642173
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 6 classes
Who owns NUCLEUS
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
What the mark covers
The products and services NUCLEUS is filed for, grouped by Nice class.
Downloadable software that enables the collection, editing, organization, modification, storage, transmission and sharing of data and information relating to the pharmaceutical drug and device and clinical research industries
Business networking involving the provision of business, professional, and social networking activities for healthcare professionals; providing business information and updates on participants, events, and activities of users in the field of the pharmaceutical drug, pharmaceutical device, and clinical research industries; operating an on-line marketplace for sellers and buyers of goods and services in the field of the pharmaceutical drug, pharmaceutical device, and clinical research industries; providing on-line trade directory services featuring names, contacts, profiles, portfolios, reviews, experience, pricing, catalogs and other information; all of the aforementioned services in relation to the pharmaceutical drug device and clinical research industries
Automated Clearing House (ACH) transaction processing services; processing of credit card payments; financial transaction services, namely, providing secure commercial transactions and payment options
Providing on-line forums for transmission of messages among social media network users concerning the pharmaceutical drug, pharmaceutical device, and clinical research industries; video broadcasting services over the Internet or other communications network featuring the uploaded, posted and tagged videos of others; electronic message transmission; peer-to-peer photo sharing services, namely, electronic transmission of digital photo files among internet users; all of the aforementioned services relating to the pharmaceutical drug and device and clinical research industries
Educational services, namely, conducting programs in the field of pharmaceutical drugs, pharmaceutical devices, and clinical research
Providing a website that gives users the ability to create, manage, store, and share customized web pages featuring user-defined profiles in the field of the pharmaceutical drug, pharmaceutical device, and clinical research industries; computer services, namely, interactive hosting services which allow the users to upload, post, share, and display information and links to other websites or software on-line in the field of the pharmaceutical drug, pharmaceutical device, and clinical research industries; providing a website that gives users the ability to search for and view other users in a social media network in the field of the pharmaceutical drug, pharmaceutical device, and clinical research industries; providing a website that gives users the ability to create groups and share information in the field of the pharmaceutical drug, pharmaceutical device, and clinical research industries; providing news and information in the field of pharmaceutical drug and device development and clinical research industries; software-as-a-service (SAAS) featuring software for conducting business activities and transactions in the field of pharmaceutical drugs, pharmaceutical devices, and clinical research; providing a website featuring technology that enables users to create, manage, store and share user profiles and information
What has happened so far
Steps recorded by the USPTO, newest first.
- Report completed suspension check case still suspended
- Withdrawal of attorney granted
- Teas withdrawal of attorney received
- Report completed suspension check case still suspended
- Report completed suspension check case still suspended
- Automatic update of assignment of ownership
- Assignment of ownership not updated automatically
- Automatic update of assignment of ownership
- Report completed suspension check case still suspended
- Suspension checked - to attorney for action
10 earlier steps on the official record.
About NUCLEUS
Who owns the trademark "NUCLEUS"?
The USPTO trademark "NUCLEUS" (application 97642173) is owned by Simulations Plus, Inc.
What is the status of "NUCLEUS"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull NUCLEUS and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b0a-0b12-7221-a896-e9a038a48002
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b0a-0b12-7221-a896-e9a038a48002",
"object": "trademark",
"mark_text": "NUCLEUS",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "97642173",
"filing_date": "2022-10-21",
"nice_classes": [
9,
35,
36,
38,
41,
42
],
"owners": [
{
"name": "SIMULATIONS PLUS, INC.",
"entity_id": "ent_019eb6ff-8696-7070-82bc-57a9510d0701"
}
]
}